Zhejiang CHENGYIPHARMA's subsidiary completes the compensated recovery of land and associated assets

On June 28, 2024, the fourth board of directors' ninth meeting of Zhejiang CHENGYIPHARMA Co., Ltd. approved its subsidiary Jiangsu CHENGYIPHARMA to sign the "Asset Purchase Agreement" with relevant parties in the Qingjiangpu District of Huai'an City, transferring the land and other assets located at No. 328, Xi'an South Road, Qingjiangpu District, Huai'an City to Ninghuaipushun for compensated recovery, with a total acquisition cost of 126.988 million yuan. As of the announcement date on October 13, 2025, the company has received 114.098 million yuan after deducting land handling related expenses, completing the procedures for real estate transfer registration and other formalities. This transaction has no adverse impact on the company's normal production and operation, and it is expected to increase revenue by 9.5 million yuan this year after deducting costs and expenses, subject to the audit results